A Gupta1, J Mbwambo2, I Mteza3, S Shenoi1, B Lambdin4, C Nyandindi2, B I Doula5, S Mfaume5, R D Bruce1. 1. <label>*</label>Yale University School of Medicine, New Haven, Connecticut, USA. 2. <label><sup>†</sup></label>Muhimbili University of Health and Allied Sciences, Dar es Salaam. 3. <label><sup>‡</sup></label>Muhimbili National Hospital, Dar es Salaam. 4. <label><sup>§</sup></label>Pangaea Global AIDS Foundation, Oakland, California, USA. 5. <label><sup>¶</sup></label>Central TB Reference Laboratory, Dar es Salaam, Tanzania.
Abstract
SETTING: Active case finding is a World Health Organization (WHO) endorsed strategy for improving tuberculosis (TB) case detection. Despite WHO recommendations for active case finding among people who inject drugs (PWID), few studies have been published. The historical focus of case finding has been in populations that are human immunodeficiency virus-positive, incarcerated or at higher occupational risk. OBJECTIVE: We sought to examine the yield of active case finding among PWID newly started on methadone in Tanzania. DESIGN: Of 222 methadone clients, 156 (70%) met with study administrators; 150 consented to participate, 139 (93%) of whom were male. The median age was 34 years. A symptom-based questionnaire was developed by the investigators and administered to every consenting patient by a native Swahili speaker. RESULTS: Of the 150 patients surveyed, 16 (11%) had one or more TB symptoms and were referred for laboratory testing. Six new TB cases were identified in this active case finding program, with a prevalence of 4%. CONCLUSION: This study presents the first data on TB prevalence in a population of PWID in Tanzania. This prevalence is 23 times that of the general Tanzanian TB prevalence of 0.2%. These results have significant implications for TB control.
SETTING: Active case finding is a World Health Organization (WHO) endorsed strategy for improving tuberculosis (TB) case detection. Despite WHO recommendations for active case finding among people who inject drugs (PWID), few studies have been published. The historical focus of case finding has been in populations that are human immunodeficiency virus-positive, incarcerated or at higher occupational risk. OBJECTIVE: We sought to examine the yield of active case finding among PWID newly started on methadone in Tanzania. DESIGN: Of 222 methadone clients, 156 (70%) met with study administrators; 150 consented to participate, 139 (93%) of whom were male. The median age was 34 years. A symptom-based questionnaire was developed by the investigators and administered to every consenting patient by a native Swahili speaker. RESULTS: Of the 150 patients surveyed, 16 (11%) had one or more TB symptoms and were referred for laboratory testing. Six new TB cases were identified in this active case finding program, with a prevalence of 4%. CONCLUSION: This study presents the first data on TB prevalence in a population of PWID in Tanzania. This prevalence is 23 times that of the general Tanzanian TB prevalence of 0.2%. These results have significant implications for TB control.
Authors: Mark L Williams; Sheryl A McCurdy; Anne M Bowen; Gad P Kilonzo; John S Atkinson; Michael W Ross; M T Leshabari Journal: AIDS Educ Prev Date: 2009-10
Authors: Lillian Mtei; Mecky Matee; Oliver Herfort; Muhammad Bakari; C Robert Horsburgh; Richard Waddell; Bernard F Cole; Jenni M Vuola; Susan Tvaroha; Barry Kreiswirth; Kisali Pallangyo; C Fordham von Reyn Journal: Clin Infect Dis Date: 2005-04-12 Impact factor: 9.079
Authors: R N Peck; A Luhanga; S Kalluvya; J Todd; S Lugoba; D W Fitzgerald; J A Downs Journal: Int J Tuberc Lung Dis Date: 2012-06-12 Impact factor: 2.373
Authors: Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn Journal: Lancet Infect Dis Date: 2010-02 Impact factor: 25.071
Authors: Barrot H Lambdin; Jennifer Lorvick; Jessie K Mbwambo; John Rwegasha; Saria Hassan; Paula Lum; Alex H Kral Journal: Int J Drug Policy Date: 2017-06-17
Authors: Omary Ubuguyu; Olivia C Tran; Robert Douglas Bruce; Frank Masao; Cassian Nyandindi; Norman Sabuni; Sheryl McCurdy; Jessie Mbwambo; Barrot H Lambdin Journal: Int J Drug Policy Date: 2016-03-11
Authors: Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer Journal: Lancet Date: 2016-03-24 Impact factor: 79.321
Authors: Olivia C Tran; Robert Douglas Bruce; Frank Masao; Omary Ubuguyu; Norman Sabuni; Jessie Mbwambo; Barrot H Lambdin Journal: J Acquir Immune Defic Syndr Date: 2015-06-01 Impact factor: 3.731
Authors: L H Chaisson; F Naufal; P Delgado-Barroso; H S Alvarez-Manzo; K O Robsky; C R Miller; J E Golub; A E Shapiro Journal: Int J Tuberc Lung Dis Date: 2021-06-01 Impact factor: 3.427